But he noted that Mr. Trump had held back on an executive order the industry fiercely opposed, which would tie some drug prices to the prices paid by other countries — called “most-favored nation” drug pricing. “President Trump is working to ensure American patients are no longer forced to pay outrageously higher drug prices than those in other countries,” Mr. Deere said. “President Trump signed four executive orders earlier this summer. However, he did not release the final executive order on ‘most-favored nation’ drug pricing, giving drug companies a month to come up with a counterproposal. Last Sunday, Mr. Trump released the order, which calls for the establishment of pilot programs tying some Medicare drugs to prices abroad.

Source: New York Times September 18, 2020 20:43 UTC